Otros idiomas Pacific Biosciences of California, Inc.

Acciones

PACB

US69404D1081

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1,75 ^USD	+3,55 %		+26,81 %	-82,16 %

23/04	PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : JPMorgan Chase es neutral	ZM
18/04	PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : Scotiabank da una recomendación de compra	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries	01/05
Sector Update: Health Care Stocks Higher Late Afternoon	16/04
Sector Update: Health Care	16/04
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	16/04
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance	16/04
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	16/04
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
PacBio Grants Equity Incentive Award to New Employee	22/03
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions	12/03
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	12/03
PacBio to Present at Upcoming Investor Conferences	26/02
Federal Circuit Affirms Claim Construction And How It Applies	21/02
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	15/02
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M	15/02
Pacific Biosciences: Q4 Earnings Snapshot	15/02
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15/02
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results	15/02
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch	13/02
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	05/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Pacific Biosciences of California, Inc.

Acciones

PACB

US69404D1081

Otros idiomas

Filtros